Public Act 101-0278
 
HB3097 EnrolledLRB101 00211 KTG 45213 b


  
    AN ACT concerning public aid.
  
 
    Be it enacted by the People of the State of Illinois,
 
represented in the General Assembly:
  
 
 
    Section 5. The Illinois Public Aid Code is amended  by 
adding Section 12-4.52 as follows:
 
    (305 ILCS 5/12-4.52 new)
    Sec. 12-4.52. Prescriber   education.
    (a) The Department of Healthcare and Family Services shall 
develop, in collaboration with a public university  that has a 
Doctor of Pharmacy Professional Program and is located in a 
county with a population of more than 3,000,000, a program 
designed to provide
  prescribing physicians under the medical 
assistance program with an evidence-based, non-commercial 
source of the  latest
  objective   information  about  
pharmaceuticals.  Information  shall  be
  presented to prescribing 
physicians by  specially trained  pharmacists,  nurses,  or
  other   
health   professionals   to  assist  prescribing physicians  in  
making
  appropriate therapeutic recommendations.
    (b) The prescriber   education program shall consist of 2 
components: a web-based curriculum and an academic educator 
outreach. The program shall contract with clinical pharmacists 
to provide scheduled visits with prescribing physicians to 
update them on the latest research concerning medication usage 
and new updates on disease states in an unbiased manner. 
    (c) Education provided under the prescriber   education 
program shall include, but not be limited to, disease-based 
educational modules on the treatment of chronic non-cancer 
pain, diabetes, hypertension, hyperlipidemia, respiratory 
syncytial virus, and nicotine dependence. New modules may be 
created periodically as needed and existing module content 
shall be reviewed and updated on an annual or as-needed basis. 
Educational modules provided under the program shall provide 
prescribing physicians with continuing medical education 
credit. 
    (d) Additional resources provided under the prescriber   
education program shall include, but not be limited to, the 
following: 
        (1) a drug information response center available to 
    prescribing physicians that provides thorough and timely 
    in-depth answers to any questions a prescribing physician 
    may have within 48 hours after a question is received; and 
        (2) information on drug utilization trends within 
    individual and group practices. 
  


Effective Date:  1/1/2020